Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis

BackgroundCurrent treatment modalities for Major Depressive Disorder have variable efficacies and a variety of side effects. To amend this, many trials for short term, well tolerated monotherapies are underway. One such option is Zuranolone (SAGE-217), which is a recent FDA approved antidepressant f...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Abdullah Ahmad, Abdul Rafeh Awan, Natasha Nadeem, Aamir Shahid Javed, Mobeen Farooqi, Muhammed Daniyal, Hassan Mumtaz
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2024-04-01
Цуврал:	Frontiers in Neuroscience
Нөхцлүүд:	Zuranolone major depressive disorder depression postpartum depression antidepressants essential tremors
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fnins.2024.1361692/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!